Case Studies in Addressing Mental Health and Improving Outcomes for People with HIV (Web) Logo
  • Case Studies in Addressing Mental Health and Improving Outcomes for People with HIV (Web)

  • Assessment

    Please answer the following questions based on what you learned in this activity.
  • Congratulations. The best choice is B. Duloxetine is a first-line option for the treatment of major depressive disorder, with evidence of responsiveness for symptoms in a first degree relative. A is incorrect because the patient endorses difficulty with medication adherence; because of paroxetine’s short half-life, the patient may frequently experience symptoms of withdrawal if they are not compliant. C is incorrect because bupropion XR is an activating medication and can exacerbate generalized anxiety symptoms at initiation. D is incorrect because, although the patient did not have an adequate trial of sertraline due to non-compliance, they also have a diagnosis of irritable bowel syndrome, which could be exacerbated by sertraline.

    References: Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults. Can J Psychiatry. 2024;69(9): 641-87. Doi: 10.1177_07067437241245384.

  • Sorry, the correct answer is B. Duloxetine is a first-line option for the treatment of major depressive disorder, with evidence of responsiveness for symptoms in a first degree relative. A is incorrect because the patient endorses difficulty with medication adherence; because of paroxetine’s short half-life, the patient may frequently experience symptoms of withdrawal if they are not compliant. C is incorrect because bupropion XR is an activating medication and can exacerbate generalized anxiety symptoms at initiation. D is incorrect because, although the patient did not have an adequate trial of sertraline due to non-compliance, they also have a diagnosis of irritable bowel syndrome, which could be exacerbated by sertraline.

    References: Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults. Can J Psychiatry. 2024;69(9): 641-87. Doi: 10.1177_07067437241245384.

     

  • Congratulations. The best answer is C.  A PHQ-9 score of 21 indicates severe depressive symptoms, thus both psychotherapy (i.e., CBT, interpersonal therapy, or behavioral activation) and pharmacotherapy are recommended in combinations   A is incorrect because, although CBT is a recommended therapeutic intervention, the severity of depressive symptoms would be best treated in combination with medication.  B is incorrect with similar rationale to why A is incorrect (i.e., combination of both psychotherapy and medication).  D is incorrect because antipsychotics are best utilized as augmentation agents to antidepressants when partially responsive to monotherapy.

    Reference: Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults.  Can J Psychiatry. 2024;69(9): 641-87. Doi: 10.1177_07067437241245384.

  • Sorry, the best answer is C.  A PHQ-9 score of 21 indicates severe depressive symptoms, thus both psychotherapy (i.e., CBT, interpersonal therapy, or behavioral activation) and pharmacotherapy are recommended in combinations   A is incorrect because, although CBT is a recommended therapeutic intervention, the severity of depressive symptoms would be best treated in combination with medication.  B is incorrect with similar rationale to why A is incorrect (i.e., combination of both psychotherapy and medication).  D is incorrect because antipsychotics are best utilized as augmentation agents to antidepressants when partially responsive to monotherapy.

    Reference: Lam RW, Kennedy SH, Adams C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults.  Can J Psychiatry. 2024;69(9): 641-87. Doi: 10.1177_07067437241245384.



  • Congratulations. The best answer is A. Both mental health and HIV outcomes improve when patients receive mental health treatment since untreated depression in HIV makes all outcomes worse.

    Reference: Safren SA, O’Cleirigh C, Andersen LS, et al. Treating depression and improving adherence in HIV care with task-shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial. J Int AIDS Soc. 2021;24(10): e25823. Doi: 10.1002/jia2.25823.

  • Sorry, the best answer is A. Both mental health and HIV outcomes improve when patients receive mental health treatment since untreated depression in HIV makes all outcomes worse.

    Reference: Safren SA, O’Cleirigh C, Andersen LS, et al. Treating depression and improving adherence in HIV care with task-shared cognitive behavioural therapy in Khayelitsha, South Africa: a randomized controlled trial. J Int AIDS Soc. 2021;24(10): e25823. Doi: 10.1002/jia2.25823.

  • Evaluation

    To receive your CME/CE credit for participating in this activity, please complete the following evaluation.
  •  
  •  
  •  
  •  
  • Please provide the following informaiton to receive your CME/CE Certificate.


  • The certificate emails auto-generated by this form are blocked by comcast.net email addresses. Please use an alternate email address if possible, or contact CEServices@academycme.org after submitting your form. **

  • This educational activity was certified for a maximum of 1.0 AMA PRA Category 1 Credits(TM), 1.0 ANCC Contact Hours, 1.0 AAPA Category 1 CME credits, and 1.0 ACPE Contact Hours.

  • 1.25

  • 1.0

  • 0.75

  • 0.5

  • 0.0

  • Should be Empty: